According to Cognitive Market Research, the global blood group typing market size is USD XX million in 2023 and will expand at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

The global blood group typing market will expand significantly by 8.8% CAGR between 2024 to 2031.
North America held the major market of more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Europe accounted for a share of over XX% of the global market size of USD XX million.
Asia Pacific held a market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Latin America's market will have more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The blood group typing industry is set to rise due to increased blood group ownership rates, rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce. Increasing online retail channels further bolster demand, while cultural significance and investment appeal contribute to its enduring popularity.
The blood group typing market is driven by rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce.
Antibody Screenings are anticipated to form the majority of blood group owners in the years to come.

Current Scenario of the Blood Group Typing Market

Key Drivers of the Blood Group Typing Market

The growing incidence of chronic illnesses and the increase in surgical operations necessitates the need for blood donations

The demand for blood has grown as chronic diseases and the surgical procedures necessary to treat them have become more common. Blood transfusions are typically necessary for patients with chronic illnesses to manage their symptoms, and large volumes of blood are required for surgical procedures, particularly major surgeries, to ensure safe and effective results. As a result, the need for blood has steadily increased within the healthcare system, which has led to a rise in blood donation rates. The market is anticipated to benefit from this. To treat patients with chronic illnesses and those having difficult surgical operations, the American National Red Cross (2023) estimates that every day, over 29,000 units of red blood cells are required in US hospitals and emergency rooms. For instance, according to the National Center for Biotechnology Information, the number of people 50 years of age and older who have at least one chronic illness is predicted to rise from 71.522 million in 2020 to 142.66 million in 2050, a 99.5% increase.

Source- https://pubmed.ncbi.nlm.nih.gov/36711415/#:~:text=Of%20the%20population%2050%20years,to%2014.968%20million%20in%202050.

Blood group typing is a necessary test that establishes the Rh factor and the level of blood compatibility between the donor and the recipient prior to blood transfusions. Thus, the need for blood donations is a result of the rising prevalence of chronic illnesses and the rise in surgical procedures.

Blood Donation rates have necessitated the need for Blood Group Typing

Global blood donation rates have significantly increased over time. The need for transfusion procedures such as blood type detection and cross-matching has surged due to a rise in voluntary blood donations. The National Health Service Blood and Transplant (NHSBT) receives over 1.5 million voluntary blood donations annually, which are processed by the government before being given to hospitals and patients in need, according to an article published by the European Blood Alliance (EBA) (2019–2022).

Source- https://www.nhsbt.nhs.uk/who-we-are/a-history-of-donation-transfusion-and-transplantation/

NHSBT supplies hospitals in England with a secure and dependable supply of blood components, diagnostic services, and stem cell treatments. To do this, it depends on 1...

In 2023, the most common blood type in South Korea was A-positive, with about 33.8 percent of the total blood donations. It was followed by O-positive and B-positive.

Percentages of blood groups (fi), susceptibility, , and inverse characteristic time, m, of the exponential phase of the infection for the analyzed countries as derived for the fit to the observed data.

The Blood Group Plate market has emerged as a critical niche within the healthcare and diagnostics sector, catering to the growing need for efficient blood typing and compatibility testing. These plates play an essential role in transfusion medicine by aiding in the rapid identification of blood groups and ensuring

This statistic displays the number of individuals active on the kidney-only transplant waiting list in Eurotransplant countries in 2024, by blood group. In this year, around *** thousand individuals on the kidney transplant waiting list had the blood group O.

When according to the numbers of Wikipedia (although they are disputed) in countries like Chile, Ecuador, Colombia, Simbabwe and Mexico 59 to 85 percent of the people have blood group O and these countries officially publish extremely low COVID-19 cases and death rates per 1 million inhabitants, this may not alone result from insufficient investigations but might suggest a lower susceptibility of blood group O to the disease. The molecular biology of a virus infection pathogenesis determines the genetic target and the human phenotype-determining enzymes decide about the difference between infection and disease. In the case that O-glycosylation plays a key role in the pathogenesis of coronavirus infections, as was discussed already 14 years ago in a SARS-CoV virus infection and is currently again predicted for SARS-CoV-2 or COVID-19, this would involve the formation of hybrid, serologically A-like, O-GalNAcα1-Ser/Thr-R, Tn (“T nouvelle”) antigenic structures. Although the ACE2 (angiotensin-converting-enzyme 2) protein is defined as the primary SARS-CoV receptor, it is the history of the amino acid serine, suggesting the actual or additional binding via an intermediate hybrid O-glycan: the TMPRSS2 host protease-mobilized, virus-encoded serine molecule gets access to the host's N-acetyl-D-galactosamine (GalNAc) metabolism and the resulting intermediate, hybrid A-like/Tn structure performs the adhesion of the virus to host cells primarily independent of the ABO blood group, while the phenotype-determining sugars become the final glycosidic target. Individuals with blood group A cannot respond with either acquired or innate antibodies to the synthesis of A-like hybrid structures due to clonal selection and phenotypic accommodation of plasma proteins but perform a further (blood group-A-specific) hybrid binding. A first statistical study suggests that people with blood group A have a significantly higher risk for acquiring COVID-19, whereas people with blood group O have a significantly lower risk for the infection compared with non-O blood groups (Zhao, J. et al., 2020). While these findings await confirmations, blood group O individuals, lacking the blood group-A-determining enzyme, may develop the least molecular contact with the virus and maintain the anti-A/Tn cross-reactive, complement-dependent isoagglutinin activity, which is exerted by the polyreactive, nonimmune immunoglobulin M (IgM), representing the humoral spearhead of innate immunity and a first line of defense.Reference: Zhao, J. et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. medRxiv (2020) doi:10.1101/2020.03.11.20031096.

The Blood Group Typing market plays a crucial role in the healthcare sector, primarily facilitating safe blood transfusions, organ transplants, and prenatal diagnostics. This specialized area involves determining an individual's blood type, which is essential for preventing transfusion reactions that can endanger pa

In 2018, it was estimated that high-income countries accounted for ** percent of blood donations worldwide, although high-income countries represent just ** percent of the world population. This statistic shows the distribution of blood donations worldwide compared to population distribution in 2018, by income group.

The ABO Blood Group Reagent market plays a crucial role in the healthcare sector, particularly in blood transfusion procedures, organ transplants, and clinical diagnostics. These reagents are specifically designed to determine an individual's ABO blood type, which is essential for safe medical practices involving bl

The artificial blood cells market is projected to be valued at $2.5 billion in 2024, driven by factors such as increasing consumer awareness and the rising prevalence of industry-specific trends. The market is expected to grow at a CAGR of 12.7%, reaching approximately $7.5 billion by 2034.

The objective of this Special Eurobarometer report is to understand European citizens’ behaviour and attitudes towards donating and receiving treatment with these body substances (excluding solid organs). This will help to shape future policy for donors and recipients. The survey begins, setting the context for the topic, by establishing respondents’ experiences of donating specific body substances. It then moves on to establish attitudes to donating, either while alive or after death. Finally, the survey considers respondents’ attitudes to receiving treatment with donated body substances and the need for legislation at EU-level. This report includes a breakdown by country. It also provides detailed socio-demographic information including gender, age and education and where appropriate looks at data for the relevant age groups for each type of tissue donation. #####The results by volumes are distributed as follows: * Volume A: Countries * Volume AA: Groups of countries * Volume A' (AP): Trends * Volume AA' (AAP): Trends of groups of countries * Volume B: EU/socio-demographics * Volume C: Country/socio-demographics ---- Researchers may also contact GESIS - Leibniz Institute for the Social Sciences: http://www.gesis.org/en/home/

The Blood Type Testing market plays a crucial role in various sectors, including healthcare, transfusion services, and organ transplantation, as it ensures the safe and effective use of blood products. By accurately determining blood types, healthcare providers are able to mitigate the risks of transfusion reactions

The global blood and fluid warming cabinet market is projected to be valued at $450 million in 2024, driven by factors such as increasing consumer awareness and the rising prevalence of industry-specific trends. The market is expected to grow at a CAGR of 7.5%, reaching approximately $860 million by 2034.

The Glass Bead Blood Group Test Cards market is poised for significant growth, driven by the increasing demand for efficient and accurate blood grouping methods in various healthcare settings. These innovative test cards, which utilize glass beads to facilitate blood typing, offer a rapid and reliable solution for t

In March 2023, there were nearly ***** licensed blood banks across India. Out of which, *** were located in the northern state of *************. Following this, Maharashtra had *** licensed blood banks in the same period. Additionally, e-Rakt Kosh is an initiative, which aims to digitize the workflow of blood banks across the nation. Through e-Rakt Kosh, Indians can donate blood, find blood donors, and locate nearby blood banks.

The Blood Typing Intermediates market plays a crucial role in the healthcare and diagnostics industries, facilitating critical processes such as blood transfusions, organ transplants, and paternity testing. These intermediates are essential reagents or substances used to determine an individual's blood group and com

This statistic shows the global annual blood plasma volume collected for fractionation from 1990 to 2018, by type. In 2018, the global volume of source plasma stood at 55 million liters whereas recovered plasma stood at 6.5 million liters.

The global blood bag machine market is projected to be valued at $360 million in 2024, driven by factors such as increasing consumer awareness and the rising prevalence of industry-specific trends. The market is expected to grow at a CAGR of 4.5%, reaching approximately $550 million by 2034.